JPH10204082A5 - - Google Patents

Info

Publication number
JPH10204082A5
JPH10204082A5 JP1997325116A JP32511697A JPH10204082A5 JP H10204082 A5 JPH10204082 A5 JP H10204082A5 JP 1997325116 A JP1997325116 A JP 1997325116A JP 32511697 A JP32511697 A JP 32511697A JP H10204082 A5 JPH10204082 A5 JP H10204082A5
Authority
JP
Japan
Prior art keywords
thiophene
benzo
alkyl
piperidin
benzoyl
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
JP1997325116A
Other languages
English (en)
Japanese (ja)
Other versions
JPH10204082A (ja
Filing date
Publication date
Application filed filed Critical
Publication of JPH10204082A publication Critical patent/JPH10204082A/ja
Publication of JPH10204082A5 publication Critical patent/JPH10204082A5/ja
Withdrawn legal-status Critical Current

Links

JP9325116A 1996-10-25 1997-10-20 選択的エストロゲンレセプターモジュレーターとしての活性を有する置換されたベンゾ［ｂ］チオフェン化合物 Withdrawn JPH10204082A (ja)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US2905696P 1996-10-25 1996-10-25
US60/029056 1996-10-25

Publications (2)

Publication Number Publication Date
JPH10204082A JPH10204082A (ja) 1998-08-04
JPH10204082A5 true JPH10204082A5 (enExample) 2005-06-30

Family

ID=21846972

Family Applications (1)

Application Number Title Priority Date Filing Date
JP9325116A Withdrawn JPH10204082A (ja) 1996-10-25 1997-10-20 選択的エストロゲンレセプターモジュレーターとしての活性を有する置換されたベンゾ［ｂ］チオフェン化合物

Country Status (7)

Country Link
US (1) US5962475A (enExample)
EP (1) EP0838464B1 (enExample)
JP (1) JPH10204082A (enExample)
AT (1) ATE249454T1 (enExample)
CA (1) CA2218756A1 (enExample)
DE (1) DE69724733T2 (enExample)
ES (1) ES2206664T3 (enExample)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1997025033A1 (en) 1995-10-31 1997-07-17 Eli Lilly And Company Antithrombotic diamines
AU7896100A (en) * 1999-10-14 2001-04-23 Endorecherche Inc. Selective estrogen receptor modulators in the treatment or reduction of the riskof acquiring hypertension, cardiovascular diseases, and insulin resistance
WO2001035946A2 (en) * 1999-11-15 2001-05-25 New Millennium Pharmaceutical Research, Inc. Intranasal administration of raloxifene and tamoxifen
US6471979B2 (en) 1999-12-29 2002-10-29 Estrogen Vascular Technology, Llc Apparatus and method for delivering compounds to a living organism
EP1278493A4 (en) * 1999-12-29 2006-09-27 Cell Medical Inc X DEVICE AND METHOD FOR ADMINISTERING COMPOUNDS TO LIVING ORGANISM
WO2002056903A2 (en) * 2001-01-17 2002-07-25 Praecis Pharmaceuticals Inc. Methods for treating hormone associated conditions using a combination of lhrh antagonists and specific estrogen receptor modulators
EE200300537A (et) * 2001-05-01 2004-04-15 Pfizer Products Inc. Meetod madalaannuselise farmatseutilise kompositsiooni tootmiseks
JP2004531559A (ja) * 2001-05-22 2004-10-14 イーライ・リリー・アンド・カンパニー エストロゲン欠乏または内因性エストロゲンに対する異常な生理反応に関連する疾患を抑制するためのテトラヒドロキノリン誘導体
WO2002094788A1 (en) 2001-05-22 2002-11-28 Eli Lilly And Company 2-substituted 1,2,3,4-tetrahydroquinolines and derivatives thereof, compositions and methods
CZ2004118A3 (cs) 2001-07-31 2004-09-15 Pfizer Products Inc. Farmaceutický prostředek, kit a způsoby zahrnující kombinaci činidla estrogenový agonist/antagonist, estrogenu a progestinu
NZ537138A (en) 2002-07-22 2007-11-30 Lilly Co Eli Selective estrogen receptor modulators containing a phenylsulfonyl group
EP3608317A1 (en) * 2012-01-12 2020-02-12 Yale University Compounds & methods for the enhanced degradation of targeted proteins & other polypeptides by an e3 ubiquitin ligase
EP3192795B1 (en) 2012-10-24 2020-12-02 The Board of Trustees of the University of Illionis Compositions and methods for treating estrogen-related medical disorders
ES2774935T3 (es) 2012-10-24 2020-07-23 Univ Illinois Composiciones y métodos para tratar trastornos médicos relacionados con estrógeno
JP6644268B2 (ja) * 2018-03-22 2020-02-12 横浜ゴム株式会社 タイヤ用ゴム組成物及びスタッドレスタイヤ
WO2020014440A1 (en) * 2018-07-12 2020-01-16 Eli Lilly And Company Selective estrogen receptor degraders

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB2097788B (en) * 1981-04-03 1985-04-24 Lilly Co Eli Benzothiophene compounds and process for preparing them
JP3157882B2 (ja) * 1991-11-15 2001-04-16 帝国臓器製薬株式会社 新規なベンゾチオフエン誘導体
TW366342B (en) * 1992-07-28 1999-08-11 Lilly Co Eli The use of 2-phenyl-3-aroylbenzothiophenes in inhibiting bone loss
US5482949A (en) * 1993-03-19 1996-01-09 Eli Lilly And Company Sulfonate derivatives of 3-aroylbenzo[b]thiophenes
US6756388B1 (en) * 1993-10-12 2004-06-29 Pfizer Inc. Benzothiophenes and related compounds as estrogen agonists
US5492921A (en) * 1994-09-20 1996-02-20 Eli Lilly And Company Benzothiophene compounds, compositions, and methods for inhibiting aortal smooth muscle proliferation
US6703407B1 (en) * 1994-09-20 2004-03-09 Eli Lilly And Company Benzofuran compounds, compositions, and methods
US5589482A (en) * 1994-12-14 1996-12-31 Pfizer Inc. Benzo-thiophene estrogen agonists to treat prostatic hyperplasia
US5552401A (en) * 1995-02-28 1996-09-03 Eli Lilly And Company 2-benzyl-3-arylbenzothiophenes
US5705507A (en) * 1995-03-10 1998-01-06 Eli Lilly And Company Aplha-substituted-3-benzyl-benzofurans
EP0738725A3 (en) * 1995-04-21 1997-03-05 Lilly Co Eli Benzothiophenes with basic side chains

Similar Documents

Publication Publication Date Title
JPH10204082A5 (enExample)
HUP0100615A2 (hu) Szubsztituált 2-(2,6-dioxo-3-fluoro-piperidin-3-il)-izoindolinok és ezek alkalmazása TNFalfa-szint csökkentésére
JP2002543183A5 (enExample)
RU99128073A (ru) Замещенные 2-(2,6-диоксопиперидин-3-ил)-фталимиды и -1-оксоизоиндолины и способ снижения уровней фноа
HUP0302943A2 (hu) Új heterociklusos vegyületek, előállításuk és alkalmazásuk gyógyszerekként, különösen antibakteriális szerekként
JP2002502874A5 (enExample)
KR960706477A (ko) 신규한 이미다졸 유도체 및 이의 제조방법(Novel imidazole derivative and process for producing the same)
RU2008119651A (ru) Производные дикарбоновых кислот и их применение
NO176094C (no) Analogifremgangsmåte for fremstilling av ringsubstituerte 2-amino-1,2,3,4-tetrahydronaftalener
RU2001116117A (ru) Новые пиперазиновые и пиперидиновые соединения
JPH1036206A5 (enExample)
KR930703271A (ko) 퀴스퀄레이트 수용체에 대한 친화성이 있는 퀴녹살린 유도체
JP2001518468A5 (enExample)
ATE95816T1 (de) 2-((4-piperidinyl)methyl>-1,2,3,4tetrahydroisochinolin-derivate, ihre herstellung und ihre therapeutische verwendung.
RU2002112329A (ru) Новые фторалкилзамещенные циклотрисилоксаны, их использование для получения новых полимеров и новые полимеры
RU93005087A (ru) 3-(тиазолидинилбутил-4-пиперазинил)-ih-индазолы
DE69131057D1 (de) 3-[1,Thiazolidinylbutyl-4-piperazinyl]-1H-Indazole, Verfahren zu ihrer Herstellung und ihre Verwendung als Medikamente
JPS59106497A (ja) ニトロソ尿素化合物および医薬組成物
AU676348B2 (en) New 2(1H)-quinolone compounds, process for their preparationand the pharmaceutical compositions which contain them
JP2001072649A5 (enExample)
NO173276C (no) Analogifremgangsm}te for fremstilling av terapeutisk aktive 1,4-disubstituerte-piperidinylderivater
DE3167968D1 (en) Cyclopropyl methyl piperazines, process for their preparation and their use in therapeutics
HUP9701325A1 (hu) Új 2,3-benzodiazepin-származékok
EP1027055A4 (en) 3-CARBOYLKOXY-2,3-DIHYDRO-1H-PHENOTHIAZIN-4 (10H] -ONE DERIVATIVES
JP2001302934A5 (enExample)